Kris Aquino revealed that she is now diagnosed with nine autoimmune diseases. On Instagram, the Queen of All Media said that ...
7h
Inquirer.net - Philippines Entertainment News on MSNKris Aquino bares 9 autoimmune diseases: ‘The odds are against my survival’Kris Aquino appealed for prayers as she revealed that aside from her six existing autoimmune diseases, she has been diagnosed ...
Allakos on Wednesday said Concentra Biosciences, controlled by life sciences-focused investment firm Tang Capital, has agreed to pay 33 cents a share in cash for the Menlo Park, Calif., company, a 52% ...
Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...
Recent power outages on Bay State are directly related to a service provided by Eversource Energy, BU Spokesperson Colin ...
15h
News-Medical.Net on MSNCommon medicines contain hidden gluten and soy, study findsA Portuguese study found that over half of paracetamol-based painkillers and a quarter of ibuprofen liquids contain gluten or ...
Mike Patterson, Curium's North American Chief Executive Officer said: "Customers are looking to simplify their business. Our ...
Huang Shan, now 45, has established herself as a leading figure in TVB news, serving as a special program producer and host. With her sharp wit and engaging style, she has been a stalwart of the TVB ...
6h
Inquirer.net - Philippines Entertainment News on MSNKris Aquino suffers from lupus flare fever, shows visible spine: ‘My now’Kris Aquino revealed her “pain and struggle” amid suffering from lupus flare fever for over two weeks now, appealing to the ...
15h
ABS-CBN on MSN'This is my now': Kris Aquino struggles with lupus flareActress-host Kris Aquino, sister of the late President Benigno Aquino III, has shared a video on Instagram showing her ...
Former actress-host Kris Aquino is suffering from seven autoimmune diseases, and here's what it's like having a lupus flare ...
BioMarin Pharmaceutical Inc. today announced that the Phase 3 PEGASUS trial evaluating PALYNZIQ® (pegvaliase-pqpz) met its primary efficacy endpoint, demonstrating a statistically significant lowering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results